Summary |
|
|||||||||||||
Variant origin |
|
|||||||||||||
Variant description |
|
|||||||||||||
Phenotypes |
View phenotypes and curated references for all genotypes (concatenated display).
|
|||||||||||||
Expression |
|
|||||||||||||
Notes |
Mapping and Phenotype information for this QTL, its variants and associated markersJ:61489A genome scan with an average marker resolution of 20 cM was conducted on 6 month old male mice from a (C57BL/6 x 129SvIR)F2 intercross to map QTLs affecting susceptibility to hyperinsulinemia. Female mice of either strain do not develop hyperinsulinemia and were excluded from the study. The 129SvIR strain carries a mutation in the insulin receptor gene on Chromosome 8 and develops extreme hyperinsulinemia (elevated blood insulin). C57BL/6 does not develop hyperinsulinemia with or without mutation to the insulin receptor gene. The authors mapped 2 major QTLs involved in modulating blood insulin levels: Insq7 on chromosome 2 spanning 27.6 cM - 42.9 cM (LOD = 5.58 at D2Mit151) and Insq9 on chromosome 10 spanning 29 cM - 69 cM (LOD = 5.58 at D10Mit42). Also mapped were 3 suggestive QTLs: Insq6 on Chromosome 1 spanning 38.3 cM - 59.7 cM (LOD = 3.58 at D1Mit19), Insq8 on Chromosome 6 at 56.6 cM (LOD = 2.79 at D6Mit201), and Insq10 on Chromosome 12 at 44.1 cM (LOD = 3.11 at D12Mit231). Insq7 on Chromosome 2 and Insq9 on Chromosome 10 span a broad region and may contain multiple genes modulating plasma insulin Chromosome |
|||||||||||||
References |
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|